Skin patch developed for prostate cancer
Researchers from the Imperial College London have developed a new way to deliver prostate cancer therapy: a skin patch.
Prostate cancer’s growth is fueled by testosterone, the male sex hormone, and many current treatments involve decreasing--or completely cutting off--the body's production of the hormone. Existing therapies often require patients to take estrogen – the female sex hormone – with the goal of reducing testosterone production.
Unfortunately, ramping up estrogen levels in the body can bring significant side effects. When delivered via injection, many men suffer menopause-like reactions; oral estrogen pills, meanwhile, can damage the liver.
The scientists say the skin patch doesn’t cause those side effects, while reducing the testosterone production down to the level of castration. The prostate cancer patch is still only in testing.